Haig P. Bozigian, Chief Development Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 34,536 shares at $82.56 ($2.9M) on 2019-06-13, disclosed to the SEC on 2019-06-17.
Open-market sale of $2.9M NBIX by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.56 | 15,836 | $1.3M | 45.8% |
| 2 | $82.56 | 15,836 | $1.3M | 45.8% |
| 3 | $83.29 | 1,432 | $119K | 4.2% |
| 4 | $83.29 | 1,432 | $119K | 4.2% |
| Total | $82.62 avg | 34,536 | $2.9M | 100% |
| Filing → |
| NBIX | SELL | 2020-08-07 | $537K | — | Filing → |
| NBIX | SELL | 2020-05-14 | $14.2M | — | Filing → |
| NBIX | SELL | 2020-04-28 | $385K | — | Filing → |